Publications

Author

Title

Year sorteringsordning

Fulltext

Georgiadis, Panagiotis
Liampa, Irene
Hebels, Dennie G; et al.

Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis
BMC Genomics, 18

2017

-

Spaeth, Florentin
Wibom, Carl
Krop, Esmeralda J. M.; et al.

Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before Diagnosis
Cancer Research, 77(6): 1408-1415

2017

-

Krauskopf, Julian
de Kok, Theo M
Hebels, Dennie G; et al.

MicroRNA profile for health risk assessment: environmental exposure to persistent organic pollutants strongly affects the human blood microRNA machinery
Scientific Reports, 7

2017

-

Späth, Florentin
Andersson, Ulrika
Dahlin, Anna M.; et al.

Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study
Tumor Biology, 37(8): 11065-11072

2016

Download

Hosnijeh, Fatemeh Saberi
Portengen, Lutzen
Späth, Florentin; et al.

Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: a nested case-control study and meta-analyses
International Journal of Cancer, 138(10): 2357-2367

2016

-

Wibom, Carl
Späth, Florentin
Dahlin, Anna M.; et al.

Investigation of Established Genetic Risk Variants for Glioma in Prediagnostic Samples from a Population-Based Nested Case-Control Study
Cancer Epidemiology, Biomarkers and Prevention, 24(5): 810-816

2015

-

Nieters, Alexandra
Luczynska, Anna
Becker, Susen; et al.

Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition
Carcinogenesis, 35(12): 2716-2722

2014

-

Wibom, Carl
Spaeth, Florentin
Dahlin, Anna; et al.

Glioma Gwas Hits - Markers for Risk or for Prognosis?
Neuro-Oncology, 16(Suppl. 2): ii109-ii110

2014

-


Page Editor: Maria Wing

Print page